Inflammatory myopathies

Muscle Tissue Transcriptome of Idiopathic Inflammatory Myopathy Reflects the Muscle Damage Process by Monocytes and Presence of Skin Lesions

Arthritis RheumatolPublished Mechanistic study

Authors' conclusion

Our study highlights a significant involvement of monocytes in muscle damage and delineates pathologic differences among IIM subtypes. DM was characterized by complement and interferon-α and γ signaling, whereas ARS-DM was associated with OXPHOS.

Study context

Population
Patients with idiopathic inflammatory myopathy (IIM) (dermatomyositis (DM) or PM) with muscle biopsy samples
Participants
16 / 9 / 7
Comparison
DM vs PM; ARS-DM within DM
  • DMn = 16
  • PMn = 9reference
  • ARS-DMn = 7
Outcome
Transcriptomic and immunophenotypic features of IIM muscle
Methodological detailsbulk RNA-sequencing, weighted gene coexpression network analysis (WGCNA), differentially expressed gene (DEG) analysis, gene set variation analysis, deconvolution
  • Bulk RNA-sequencing
  • WGCNA
  • DEG analysis
  • Gene set variation analysis
  • Deconvolution

Main finding

As reported in the abstract

  • Significant positive correlations between serum creatine kinase (CK) and gene modules of cellular respiration, phagocytosis and oxidative phosphorylation (OXPHOS)
  • Significant positive correlations between CK and proportions of CD16-positive and negative monocytes and myeloid dendritic cells
  • DM: enrichment of complement and interferon-α and γ pathway genes vs PM
  • ARS-DM: higher proportion of Th1 cells and DEGs related to OXPHOS
  • Serum Krebs von den Lungen-6 correlated with gene modules of extracellular matrix and TGF-β signaling pathway

Original publication

Muscle Tissue Transcriptome of Idiopathic Inflammatory Myopathy Reflects the Muscle Damage Process by Monocytes and Presence of Skin Lesions. Arthritis Rheumatol. Published 3 September 2024. doi:10.1002/art.42972

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.